People

Experic, which offers a range of development and manufacturing services for DPIs, has announced the appointment of former Catalent Drug Delivery Solutions General Manager Matthew Mollan as Chief Executive Officer. According to the company, previous… Read more . . .

CDMO Kindeva has announced that David Stevens has taken over the role of CEO, effective January 1, 2026. Stevens succeeds Milton Boyer, who will remain a member of the board of directors, the company said. Stevens… Read more . . .

Iconovo, which said earlier this year that it would discontinue internal development and would focus on commercialization of its existing DPI platforms, has announced that CEO Johan Wäborg will step down, and advisor Anders Månsson… Read more . . .

OINDP specialist CDMO Kenox Pharmaceuticals has announced the appointment of Julianne Berry as VP of R&D and Manufacturing. Berry was most recently VP, Respiratory Product Development at Odin Pharmaceuticals and has extensive experience in the development of inhaled… Read more . . .

Inhalation CDMO Bespak has announced the appointment of former automotive industry executive Tarik Hage as Chief Commercial Officer. Hage was most recently VP of Commercial and Business Development at GKN Automotive, where he had worked… Read more . . .

Inhaled drug developer Avalyn Pharma has announced the appointments of Jill Denning as Senior VP, Clinical Development Operations, and Kimberley Cummings as Senior VP, Regulatory Affairs. Denning was most recently VP of Clinical Development at Kinevant… Read more . . .

Inhaled drug developer MannKind Corporation has announced the appointment of Ajay Ahuja as Executive VP and Chief Medical Officer. Ahuja was most recently Development and Launch Leader at Kardigan Bio; his previous experience includes executive roles at… Read more . . .

Inhaler testing specialist Copley Scientific has announced the appointment of Paul Martin as Head of Business Development. Martin, who has extensive experience in business development within the OINDP space, was most recently Associate Director of… Read more . . .

Inhaled epinephrine developer De Motu Cordis (DMC) announced that its CEO Peter O’Neill has stepped down and that Chief Financial Officer John Corbett will serve as Interim CEO. The company says that it is preparing… Read more . . .